Document is current
Any future updates will be listed below
-
Authors
Lamo-Espinosa, José María
Prósper, Felipe
Blanco, Juan F.
Sánchez-Guijo, Fermín
Alberca, Mercedes
García, Verónica
González-Vallinas, Margarita
García-Sancho, Javier https://orcid.org/0000-0003-4573-7930
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02123368 at ClinicalTrials.govDocuments that mention this clinical trial
Long-term efficacy of autologous bone marrow mesenchymal stromal cells for treatment of knee osteoarthritis
https://doi.org/10.1186/s12967-021-03160-2
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (Red de Terapia Celular (RETIC TerCel, RD16/0011/0003, 0005, 0015;, PIC18/00001))
Consejería de Educación, Junta de Castilla y León (Centro en Red de Medicina Regenerativa, Escalera de Excelencia CLU-2019-02))
- License Information
-
More Information
Article History
Received: 8 November 2021
Accepted: 22 November 2021
First Online: 11 December 2021
Declarations
:
: All the procedures of the original clinical trials were approved by the Institutional Review Boards of the corresponding Hospitals and by the Spanish Agency of Medicines and Medical Devices.
: Not applicable.
: J.G.S. is member of the Board of Directors of Citospin, a spin-off company of the University of Valladolid (Spain) that specializes in GMP-compliant cell production. M.A. and V.G. are employees of Citospin. The other authors declare that they have no conflicts of interest.
